INmune Bio, Inc. (INMB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for INmune Bio, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.90x | -2.21x | -6.75x | -4.16x | -5.42x | -17.06x |
| P/B Ratio | 1.76x | 2.90x | 5.31x | 1.89x | 2.05x | 5.33x |
| P/S Ratio | 829.46x | 6652.75x | 1306.23x | 303.90x | 909.04x | 18766.67x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -61738.0% | -304535.7% | -19187.7% | -6938.8% | -16106.6% | -111163.6% |
| Net Margin | -91866.0% | -300585.7% | -19360.0% | -7299.2% | -16762.4% | -109990.9% |
| EBITDA Margin | -61570.0% | -300585.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.55x | 3.14x | 2.16x | 5.92x | 18.95x | 13.51x |
| Quick Ratio | 3.55x | 3.14x | 2.16x | 5.92x | 20.21x | 13.51x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.01x | 0.27x | 0.25x | 0.19x | 0.00x |
YoY = year-over-year change. Source: FMP..